The increased levels of ET-1 associated with the Ser863Asp mutant and the decreased levels of NO in all four mutants we identified may represent a mechanism that explains how BMPR2 mutations are associated with the development of PAH. Here, EDN1 is linked to pulmonary arterial hypertension.